This inventor holds 6 USPTO granted patents and 3 published patent applications and 4 EPO patents. Top assignees: Biota Scientific Management Pty Ltd, Biota Europe Limited, Biota Scientific Pty Ltd. Active years: 2012-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Yarnton, GB (2012 - 2015)
- Oxfordshire, GB (2013 - 2016)
Company Filing History:
2 out of 54 
1 out of 6 
1 out of 1 
Years Active: 2012-2016
Title: The Innovations of Ian Collins - Pioneering Antibacterial Compounds
Introduction
Ian Collins, an accomplished inventor based in Yarnton, GB, has made significant contributions to the field of pharmaceuticals through his groundbreaking innovations. Holding six patents to his name, Collins is renowned for developing powerful antibacterial compounds that promise to advance medical treatments and improve public health.
Latest Patents
Among his latest inventions, Collins has introduced two notable patents focusing on aromatic amides and antibacterial compounds. The first patent, titled "Aromatic amides and uses thereof," details compounds of a specific formula along with their diverse derivatives, such as salts, racemates, enantiomers, and prodrugs. This invention not only identifies these compounds but also emphasizes their utility as antibacterials and outlines the processes for their manufacture. The second patent, "Antibacterial compounds," involves a novel compound along with its salts, with similar applications for antibacterial use, thereby further underlining Collins' innovative contributions to healthcare.
Career Highlights
Ian Collins has been associated with prominent companies in the scientific community, including Biota Scientific Management Pty Ltd and Biota Scientific Pty Ltd. His experience in these organizations has influenced his development of effective pharmaceutical solutions aimed at combatting bacterial infections.
Collaborations
Collins has collaborated with several notable professionals in his field, including Lloyd George Czaplewski and David John Haydon. These partnerships have fostered a collaborative environment that has enriched the innovation process, paving the way for novel therapeutic developments.
Conclusion
Ian Collins stands out as an inventive force in the realm of antibacterial pharmaceutical compounds. Through his patents and collaborations, he continues to drive forward advancements in public health, showcasing the profound impact that dedicated inventors have on society. As the field of pharmaceuticals evolves, Collins' contributions are likely to play a vital role in shaping the future of antibacterial therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile